Literature DB >> 15716531

Neuropsychiatric porphyria in patients with refractory epilepsy: report of three cases.

A S Winkler1, T J Peters, R D C Elwes.   

Abstract

OBJECTIVES: Although epileptic seizures are an infrequent feature of acute attacks of the neuropsychiatric porphyrias, there are no significant reports of porphyria in chronic epilepsy. This paper attempts to redress the balance.
METHODS: Three case reports, including detailed laboratory and molecular diagnostics.
RESULTS: Two patients with variegate porphyria and one with acute intermittent porphyria, referred within 1 year to a specialist porphyria service, with a long history of chronic refractory epileptic seizures, are described.
CONCLUSIONS: Porphyria may be an aetiological factor in some cases of chronic refractory partial or generalised epilepsy. Porphyria should also be considered if addition of a new anti-epileptic medication causes a major deterioration in the epilepsy.

Entities:  

Mesh:

Year:  2005        PMID: 15716531      PMCID: PMC1739528          DOI: 10.1136/jnnp.2003.033951

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Aucte intermittent porphyria and epilepsy.

Authors:  R Biagini; R Tignani; A R Fifi; L Nappini
Journal:  Arch Dis Child       Date:  1979-08       Impact factor: 3.791

2.  Hyponatremia in acute intermittent porphyria probably resulting from inappropriate secretion of antidiuretic hormone.

Authors:  G D LUDWIG; M GOLDBERG
Journal:  Ann N Y Acad Sci       Date:  1963-03-05       Impact factor: 5.691

3.  Delta-aminolaevulinic acid is a potent agonist for GABA autoreceptors.

Authors:  M J Brennan; R C Cantrill
Journal:  Nature       Date:  1979-08-09       Impact factor: 49.962

4.  Neurotoxicity of delta-aminolevulinic acid and porphobilinogen.

Authors:  C A Pierach; P S Edwards
Journal:  Exp Neurol       Date:  1978-12       Impact factor: 5.330

5.  The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967.

Authors:  W A Hauser; L T Kurland
Journal:  Epilepsia       Date:  1975-03       Impact factor: 5.864

6.  MR imaging of acute intermittent porphyria mimicking reversible posterior leukoencephalopathy syndrome.

Authors:  N Utz; B Kinkel; J P Hedde; H Bewermeyer
Journal:  Neuroradiology       Date:  2001-12       Impact factor: 2.804

7.  Acute intermittent porphyria with seizures. Anticonvulsant medication-induced metabolic changes.

Authors:  R I Birchfield; M L Cowger
Journal:  Am J Dis Child       Date:  1966-12

8.  Acute intermittent porphyria with central pontine myelinolysis and cortical laminar necrosis.

Authors:  S Susa; M Daimon; Y Morita; M Kitagawa; A Hirata; H Manaka; H Sasaki; T Kato
Journal:  Neuroradiology       Date:  1999-11       Impact factor: 2.804

9.  Grand mal seizures and acute intermittent porphyria. The problem of differential diagnosis and treatment.

Authors:  C R Magnussen; J M Doherty; R A Hess; D P Tschudy
Journal:  Neurology       Date:  1975-12       Impact factor: 9.910

10.  L-tryptophan: a common denominator of biochemical and neurological events of acute hepatic porphyria?

Authors:  D A Litman; M A Correia
Journal:  Science       Date:  1983-12-02       Impact factor: 47.728

View more
  3 in total

Review 1.  Epilepsy and inborn errors of metabolism in adults: a diagnostic approach.

Authors:  F Sedel; I Gourfinkel-An; O Lyon-Caen; M Baulac; J-M Saudubray; V Navarro
Journal:  J Inherit Metab Dis       Date:  2007-10-22       Impact factor: 4.982

Review 2.  Acute porphyrias - A neurological perspective.

Authors:  Lea M Gerischer; Franziska Scheibe; Astrid Nümann; Martin Köhnlein; Ulrich Stölzel; Andreas Meisel
Journal:  Brain Behav       Date:  2021-10-17       Impact factor: 2.708

Review 3.  Inborn Errors of Metabolism and Epilepsy: Current Understanding, Diagnosis, and Treatment Approaches.

Authors:  Suvasini Sharma; Asuri N Prasad
Journal:  Int J Mol Sci       Date:  2017-07-02       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.